Search Thermo Fisher Scientific
MSACL 2024 US
Tradeshow
Mar 17, 2024
- Mar 22, 2024
Monterey Conference Center | 1 Portola Plaza, Monterey, CA 93940
Booth 31 & 32 | Monterey Conference Center | Monterey, CA
It was great seeing everyone at the 2024 Association of Mass Spectrometry & Advances in the Clinical Lab (MSACL).
Want to learn more about the solutions we offer? Let us know by filling out our form and we'll put you in touch with one of our experts.
2024 Breakfast workshops
Practical considerations for standardizing LC-MS assays in clinical labs
This workshop focused on the practical aspects of developing and validating LC-MS assays in clinical labs. Dr. Stefani Thomas and Dr. Tony Maus, renowned experts from esteemed institutions, shared their knowledge and experiences.
An optimized, simplified workflow for the targeted proteomic analysis of fibrinogen in 4,200 plasma samples
Speaker: Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota
Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota
Join Dr. Thomas (UMN) at MSACL 2024: "An optimized, simplified workflow for the targeted proteomic analysis of fibrinogen in 4,200 plasma samples"
FAIMS: The perfect complement to established LC-MS/MS techniques
Speaker: Anthony Maus, B.S, Ph.D., Mayo Clinic
Anthony Maus, B.S., Ph.D., Mayo Clinic
Join Dr. Maus of Mayo Clinic at MSACL 2024: FAIMS enhances clarity, reduces noise, improves agreement, maintains performance, streamlines analysis.
Unlocking the potential for large-cohort proteomic studies with the Orbitrap Astral mass platform
This workshop delved into the groundbreaking capabilities of the Orbitrap Astral Platform and its role in advancing large-cohort proteomics studies. Gained valuable insights from expert speakers Dr. Jenny Van Eyk and Dr. Yue Xuan and explored the potential for groundbreaking research.
Paradigm shift in biomarker translation: an innovative and automated pipeline to generate and select clinical-grade signature peptides during DIA discovery
Speaker: Jennifer Van Eyk, PhD, Cedars-Sinai Heart Institute
Jennifer Van Eyk, Ph.D., Cedars-Sinai Heart Institute
View Thermo Fisher Scientific's webinar from MSACL 2024 on-demand with Dr. Jenny Van Eyk of Cedars Sinai. Discover the new Orbitrap Astral MS platform.
Introducing the Orbitrap Astral mass spectrometer
Speaker: Yue Xuan, Ph.D., MBA, Thermo Fisher Scientific
Yue Xuan, Ph.D., MBA, Thermo Fisher Scientific
Join Thermo Fisher Scientific's MSACL 2024 workshop with speaker Dr. Yue Xuan exploring large-cohort proteomics with the Orbitrap Astral MS platform
Video testimonials
Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota
Dr. Thomas discusses her work in developing and validating a mass spectrometry-based assay for fibrinogen.
Erin H. Seeley, Ph.D., Director, Mass Spectrometry Imaging Facility Department of Chemistry, University of Texas at Austin
Dr. Seeley explains how the Orbitrap Fusion Lumos Tribrid Mass Spectrometer allows for seamless transitions between electro spray and MALDI analysis.
Timothy J. Garrett, Ph.D., Associate Professor, Department of Pathology, Immunology and Laboratory Medicine, Chief of Experimental Pathology, Associate Director, Southeast Center for Integrated Metabolomics, College of Medicine, University of Florida
Dr. Garrett shares how Thermo Fisher Scientific’s technology has enabled his lab to perform reproducible metabolomics and lipidomics analyses.
Posters
Wednesday, March 20 | ||
|---|---|---|
12:15 p.m. | Poster #69a | Enhanced Detection of Hemoglobin Variants by High-Resolution Accurate Mass (HRAM) Mass Spectrometry for Clinical Research |
12:15 p.m. | Poster #73a | Simultaneous detection of respiratory infectious diseases using immunoprecipitation and liquid chromatography-tandem mass spectrometry |
2:30 p.m. | Poster #61b | Unlocking the Potential of Large-Cohort Proteomics Studies With the Orbitrap Astral Mass Platform |
2:30 p.m. | Poster #73b | An in-depth and high throughput plasma proteomics workflow powered by Orbitrap Exploris 480 mass spectrometer using multi nanoparticle-based workflow |
2:30 p.m. | Poster #69b | Quantitation of a Panel of Per- and Polyfluoroalkyl Substances (PFAS) in Biological Matrix |
Thursday, March 21 | ||
|---|---|---|
9:15 a.m. | Poster #70a | Empower the Confidence for Inborn Error of Metabolism Screening: Quantitation of Amino Acids and Acylcarnitines in Dried Blood Spots by Flow Injection – Orbitrap Mass Spectrometer: |
9:15 a.m. | Poster #72a | Unleashing the Power of HT-DIA Acquisition on Orbitrap Exploris 240 – Precise and Accurate Quantitation at 260 SPD |
12:15 9.m. | Poster #72b | Quantitation of an Oral Fluid Drug Panel Including THC Using with High Resolution Accurate-Mass (HRAM) Mass Spectrometry |
2024 Breakfast workshops
Practical considerations for standardizing LC-MS assays in clinical labs
This workshop focused on the practical aspects of developing and validating LC-MS assays in clinical labs. Dr. Stefani Thomas and Dr. Tony Maus, renowned experts from esteemed institutions, shared their knowledge and experiences.
An optimized, simplified workflow for the targeted proteomic analysis of fibrinogen in 4,200 plasma samples
Speaker: Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota
Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota
Join Dr. Thomas (UMN) at MSACL 2024: "An optimized, simplified workflow for the targeted proteomic analysis of fibrinogen in 4,200 plasma samples"
FAIMS: The perfect complement to established LC-MS/MS techniques
Speaker: Anthony Maus, B.S, Ph.D., Mayo Clinic
Anthony Maus, B.S., Ph.D., Mayo Clinic
Join Dr. Maus of Mayo Clinic at MSACL 2024: FAIMS enhances clarity, reduces noise, improves agreement, maintains performance, streamlines analysis.
Unlocking the potential for large-cohort proteomic studies with the Orbitrap Astral mass platform
This workshop delved into the groundbreaking capabilities of the Orbitrap Astral Platform and its role in advancing large-cohort proteomics studies. Gained valuable insights from expert speakers Dr. Jenny Van Eyk and Dr. Yue Xuan and explored the potential for groundbreaking research.
Paradigm shift in biomarker translation: an innovative and automated pipeline to generate and select clinical-grade signature peptides during DIA discovery
Speaker: Jennifer Van Eyk, PhD, Cedars-Sinai Heart Institute
Jennifer Van Eyk, Ph.D., Cedars-Sinai Heart Institute
View Thermo Fisher Scientific's webinar from MSACL 2024 on-demand with Dr. Jenny Van Eyk of Cedars Sinai. Discover the new Orbitrap Astral MS platform.
Introducing the Orbitrap Astral mass spectrometer
Speaker: Yue Xuan, Ph.D., MBA, Thermo Fisher Scientific
Yue Xuan, Ph.D., MBA, Thermo Fisher Scientific
Join Thermo Fisher Scientific's MSACL 2024 workshop with speaker Dr. Yue Xuan exploring large-cohort proteomics with the Orbitrap Astral MS platform
Video testimonials
Stefani Thomas, Ph.D., DABCC, NRCC, University of Minnesota
Dr. Thomas discusses her work in developing and validating a mass spectrometry-based assay for fibrinogen.
Erin H. Seeley, Ph.D., Director, Mass Spectrometry Imaging Facility Department of Chemistry, University of Texas at Austin
Dr. Seeley explains how the Orbitrap Fusion Lumos Tribrid Mass Spectrometer allows for seamless transitions between electro spray and MALDI analysis.
Timothy J. Garrett, Ph.D., Associate Professor, Department of Pathology, Immunology and Laboratory Medicine, Chief of Experimental Pathology, Associate Director, Southeast Center for Integrated Metabolomics, College of Medicine, University of Florida
Dr. Garrett shares how Thermo Fisher Scientific’s technology has enabled his lab to perform reproducible metabolomics and lipidomics analyses.
Posters
Wednesday, March 20 | ||
|---|---|---|
12:15 p.m. | Poster #69a | Enhanced Detection of Hemoglobin Variants by High-Resolution Accurate Mass (HRAM) Mass Spectrometry for Clinical Research |
12:15 p.m. | Poster #73a | Simultaneous detection of respiratory infectious diseases using immunoprecipitation and liquid chromatography-tandem mass spectrometry |
2:30 p.m. | Poster #61b | Unlocking the Potential of Large-Cohort Proteomics Studies With the Orbitrap Astral Mass Platform |
2:30 p.m. | Poster #73b | An in-depth and high throughput plasma proteomics workflow powered by Orbitrap Exploris 480 mass spectrometer using multi nanoparticle-based workflow |
2:30 p.m. | Poster #69b | Quantitation of a Panel of Per- and Polyfluoroalkyl Substances (PFAS) in Biological Matrix |
Thursday, March 21 | ||
|---|---|---|
9:15 a.m. | Poster #70a | Empower the Confidence for Inborn Error of Metabolism Screening: Quantitation of Amino Acids and Acylcarnitines in Dried Blood Spots by Flow Injection – Orbitrap Mass Spectrometer: |
9:15 a.m. | Poster #72a | Unleashing the Power of HT-DIA Acquisition on Orbitrap Exploris 240 – Precise and Accurate Quantitation at 260 SPD |
12:15 9.m. | Poster #72b | Quantitation of an Oral Fluid Drug Panel Including THC Using with High Resolution Accurate-Mass (HRAM) Mass Spectrometry |
2023 Breakfast workshops
Promising clinical applications of ICP-MS
Speaker: Jessica Colón-Franco, Ph.D., Cleveland Clinic Foundation
Speaker: Dr. Michael Lutz, Ph.D., Osteolabs GmbH Germany
New frontiers for pathogen detection using LC-MS
Speaker: Ian Lewis, Ph.D., University of Calgary, Alberta
Speaker: Tony Hu, Ph.D., Professor, Tulane University
Video testimonials
Ian Lewis, Ph.D., Associate Professor and Director of the Alberta Centre for Advanced Diagnostics
“We want to build [diagnostic] tools that will have a real impact on people's lives. We’re on the cusp of making one of those contributions, and it wouldn’t be possible without the support of Thermo Fisher Scientific.”
Jessica Colón-Franco, Ph.D., DABCC, Section Head of Clinical Biochemistry and Director of the Special Chemistry Laboratory, Cleveland Clinic
"We’re working on a method [for lead screening] using dried blood spots in tandem with ICP-MS. What inspires me in my job as a clinical chemist is the ability to provide meaningful answers for physicians and patients.”
Michael Lutz, Ph.D., Senior Adviser, Osteolabs, GmbH Germany
“We are developing clinical assays that are relevant in the field of metabolic bone disorders. We have set up ICP-MS methods that are addressing this unmet clinical need, which affects over 1 billion patients in the world.”
Chris Gill, Vancouver Island University
“My research program has been ongoing for over 20 years. Its primary focus is the development of direct mass spectrometry techniques that provide chemical measurement that’s faster, better, cheaper, and in real-time.”
Posters
Clinical Research | |
Clinical Research | Direct quantitation of 77 therapeutic and clinical toxicology drugs in dried blood spots using the fully automated Transcend DSX-1 system |
Clinical Research | High flow LC-MS analysis of plasma digest for protein identification |
2023 Breakfast workshops
Promising clinical applications of ICP-MS
Speaker: Jessica Colón-Franco, Ph.D., Cleveland Clinic Foundation
Speaker: Dr. Michael Lutz, Ph.D., Osteolabs GmbH Germany
New frontiers for pathogen detection using LC-MS
Speaker: Ian Lewis, Ph.D., University of Calgary, Alberta
Speaker: Tony Hu, Ph.D., Professor, Tulane University
Video testimonials
Ian Lewis, Ph.D., Associate Professor and Director of the Alberta Centre for Advanced Diagnostics
“We want to build [diagnostic] tools that will have a real impact on people's lives. We’re on the cusp of making one of those contributions, and it wouldn’t be possible without the support of Thermo Fisher Scientific.”
Jessica Colón-Franco, Ph.D., DABCC, Section Head of Clinical Biochemistry and Director of the Special Chemistry Laboratory, Cleveland Clinic
"We’re working on a method [for lead screening] using dried blood spots in tandem with ICP-MS. What inspires me in my job as a clinical chemist is the ability to provide meaningful answers for physicians and patients.”
Michael Lutz, Ph.D., Senior Adviser, Osteolabs, GmbH Germany
“We are developing clinical assays that are relevant in the field of metabolic bone disorders. We have set up ICP-MS methods that are addressing this unmet clinical need, which affects over 1 billion patients in the world.”
Chris Gill, Vancouver Island University
“My research program has been ongoing for over 20 years. Its primary focus is the development of direct mass spectrometry techniques that provide chemical measurement that’s faster, better, cheaper, and in real-time.”
Posters
Clinical Research | |
Clinical Research | Direct quantitation of 77 therapeutic and clinical toxicology drugs in dried blood spots using the fully automated Transcend DSX-1 system |
Clinical Research | High flow LC-MS analysis of plasma digest for protein identification |
New products
Thermo Scientific Tox Explorer Collection
The Thermo Scientific Tox Explorer Collection is an all-in-one LC-MS/MS solution that provides confident answers to scientists in forensic toxicology, clinical research toxicology, employee drug testing, and sports anti-doping. It is now available in HRAM and QQQ MS platforms.
Thermo Scientific Orbitrap Exploris 120 mass spectrometer
The Thermo Scientific Orbitrap Exploris 120 mass spectrometer sets the new standard in instrument productivity and ruggedness, delivering high confidence results for a broad range of toxicology compounds.
Thermo Scientific VeriSpray PaperSpray ion source
Improve turnaround time, reduce cost per test and minimize sample preparation with the Thermo Scientific VeriSpray PaperSpray ion source, a fully automated, high-throughput, direct ionization technique used with our newest Thermo Scientific TSQ triple quadrupole mass spectrometers.
Thermo Scientific TSQ Altis Plus mass spectrometer
With superior acquisition speeds, enhanced sensitivity, and exceptional robustness, the TSQ Altis Plus mass spectrometer delivers accuracy and precision for low-level compound detection and quantitation in complex matrices.
Orbitrap Astral mass spectrometer
The Thermo Scientific Orbitrap Astral Mass Spectrometer combines three mass analyzers: a quadrupole mass analyzer for high selectivity and high ion transmission, an Orbitrap mass analyzer for high dynamic range and high resolution measurements, and the novel Astral analyzer for fast and sensitive measurements. By combining these three mass analyzers and orchestrating the coordination of 5 separate ion packets within the instrument in parallel a new standard for mass spectrometry performance is achieved to unlock new insights into biology and disease mechanisms.
* Required field